3rd ECMED Practical Workshop

Development of strategies to transport CNS drugs across the BBB and biotechnology entrepreneurship

24-27 Oct 2016 Marseille (France)

Program

Week Mon. 24 Tue. 25 Wed. 26 Thu. 27 List

	Mon. 24	Tue. 25	Wed. 26	Thu. 27
09:00 10:00 11:00 12:00 13:00 14:00 15:00 16:00 17:00 18:00	Welcome, Introduction to the workshop 9:00 - 9:15 (15min) Welcome, Introduction to the workshop Michel Khrestchatisky, François Féron/Frederic Chavane, Roisin Owens How the blood-brain barrier controls xenobiotics permeability 9:15 - 10:00 (45min) How the blood-brain barrier controls xenobiotics permeability Pr. Jean-Michel Scherrmann, Faculty of Pharmacy, Paris, France Overcoming the Blood-Brain Barrier - The Extra Challenge for CNS Drug Development 10:00 - 10:45 (45min) Overcoming the Blood-Brain Barrier - The Extra Challenge for CNS Drug Development Dr. Christopher Untucht, AbbVie Deutschland GmbH & Co. KG, Ludwigshafen, Germany Coffee break 10:45 - 11:15 (30min) Coffee break The BBB in cerebrovascular dysfunction and seizure disorders 11:15 - 12:00 (45min) The BBB in cerebrovascular dysfunction and seizure disorders Dr. Nicola Marchi, Institute of Functional Genomics, Montpellier, France MicroRNAs in inflammation and ageing at the blood-brain barrier 12:00 - 12:45 (45min) MicroRNAs in inflammation and ageing at the blood-brain barrier Pr. Nacho Romero, The Open University, Milton Keynes, UK Lunch 12:45 - 14:00 (1h15) Lunch In vitro models of the BBB: From Animal to Human 14:00 - 15:00 (1h) In vitro models of the BBB: From Animal to Human Pr. Roméo Cecchelli, Université d’Artois, Lens, France CNS drug delivery via Receptor Mediated Transport/Transcytosis 15:00 - 16:00 (1h) CNS drug delivery via Receptor Mediated Transport/Transcytosis Dr. Michel Khrestchatisky, NICN, CNRS, Marseille, France Coffee break 16:00 - 16:30 (30min) Coffee break Innovative conducting polymer solutions for monitoring the blood brain barrier 16:30 - 17:30 (1h) Innovative conducting polymer solutions for monitoring the blood brain barrier Dr. Roisin Owens, Center of Microelectronics of Provence, Gardanne Closing remarks by students 17:30 - 18:00 (30min) Closing remarks by students	Patenting Biotech innovations 9:15 - 10:15 (1h) Patenting Biotech innovations Philippe Becker, European Patent Attorney, founder & managing partner of Becker&Associes, Paris and Aix-en Provence, France Coffee break 10:15 - 10:45 (30min) Coffee break Managing IP in a Biotech 10:45 - 11:45 (1h) Managing IP in a Biotech Lukas Voellmy, European Patent Attorney, IP Director at Innate Pharma Biotech company, Marseille, France Drafting & analysing a patent application 11:45 - 12:45 (1h) Drafting & analysing a patent application Pr. Peter Follette from Université Nice Sophia Antipolis, Nice, France Telling a clear scientific story in writing or in oral presentations 14:00 - 17:30 (3h30) Telling a clear scientific story in writing or in oral presentations Pr. Peter Follette from Université Nice Sophia Antipolis, Nice, France	Funding for research Workshop; Writing convincing grant applications 9:15 - 12:45 (3h30) Funding for research Workshop; Writing convincing grant applications Dr. David Karlin, COSENS Entrepreneurs, Marseille, France Lunch 12:45 - 14:00 (1h15) Lunch Job search Workshop; Transforming your skills into an offer of services to boost your job search 14:00 - 17:30 (3h30) Job search Workshop; Transforming your skills into an offer of services to boost your job search Dr. David Karlin, COSENS Entrepreneurs, Marseille, France	TBA 9:15 - 10:15 (1h) TBA Dr. Guillaume Jacquot, Vect-Horus, Marseille, France Coffee break 10:15 - 10:45 (30min) Coffee break TBA 10:45 - 11:45 (1h) TBA Dr. Pascaline Lécorché, Vect-Horus, Marseille, France Realization of new ideas 11:45 - 12:45 (1h) Realization of new ideas Dr. Jacques Souquet, CEO SuperSonic Imagine, Aix-en-Provence, France Lunch 12:45 - 14:00 (1h15) Lunch Creating a biotech: The case of Iproteos 14:00 - 15:00 (1h) Creating a biotech: The case of Iproteos Dr. Laura Mendieta & Dr. Roger Prades, Iproteos, Barcelona, Spain Clinical development plans for CNS drugs 15:00 - 16:00 (1h) Clinical development plans for CNS drugs Dr. Olivier Blin, Head Pharmacology Clinic, Hospital Timone, Marseille, France Coffee break 16:00 - 16:30 (30min) Coffee break The discovery and development of olesoxime for SMA: a CNS bench to bedside success story 16:30 - 17:30 (1h) The discovery and development of olesoxime for SMA: a CNS bench to bedside success story Dr. Rebecca Pruss, Former CSO Trophos, Marseille, France, Founder & director Windhover Biomed, London, UK Closing remarks by students 17:30 - 18:00 (30min) Closing remarks by students Summary and farewell 18:00 - 18:15 (15min) Summary and farewell Michel Khrestchatisky, Grigorios Kyriatzis

Online user: 1